ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "First void urine: revolutionizing potential non-invasive biomarker collection"
Episode Synopsis
Join Tara Crawford-Parks, PhD, Director for Translational R&D and Product Enablement at DNA Genotek, to explore the potential of first void urine biomarkers in clinical diagnostics. Discover how this non-invasive sampling method is transforming HPV screening and opening new possibilities for early disease detection in oncology and infectious diseases. Learn about the science behind first void urine collection, its advantages over traditional sampling methods, and how innovative devices like the Colli-Pee™ are supporting more accessible healthcare for underserved populations worldwide.
More episodes of the podcast Future Science Group
STEM Tea | Investing in our students
21/10/2025
STEM Tea | Founding Black in Neuro
09/10/2025
STEM Tea | Strengthening HBCUs
30/09/2025
In God we trust